Novogene Co., Ltd.

Novogene Co., Ltd. is a leading genomics company specializing in high-throughput sequencing and bioinformatics. At the forefront of the genomics sector, Novogene provides comprehensive sequencing services and solutions for a diverse clientele, including academic institutions, healthcare providers, and biotechnology companies. The company's offerings include whole-genome sequencing, exome sequencing, RNA sequencing, and other customized genome projects designed to advance scientific research and precision medicine. Founded in 2011 and headquartered in Beijing, China, Novogene has established itself as a key player in the global genomics market. With state-of-the-art facilities and a robust operational infrastructure, the company serves clients in over 60 countries, ensuring high-quality data and analysis. Novogene's significant contributions have impacted multiple areas, such as oncology, agricultural genomics, and infectious diseases, providing valuable insights that drive innovation and discovery. By integrating cutting-edge technology and skilled expertise, Novogene plays a crucial role in supporting the scientific and medical communities. Its commitment to research excellence and innovation positions Novogene as a noteworthy entity in the life sciences industry.